Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

38.660
+1.8204.94%
Volume:22.18M
Turnover:878.80M
Market Cap:13.69B
PE:-43.44
High:41.300
Open:38.720
Low:38.380
Close:36.840
52wk High:75.150
52wk Low:22.700
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:1.59
T/O Rate:6.27%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.890
ROE:-1.18%
ROA:-1.06%
PB:2.24
PE(LYR):-43.44
PS:4.87

Loading ...

Vikail Pharma’s Vicagrel Antithrombotic Drug Wins China Filing Acceptance for Market Approval

Reuters
·
Jun 30

Everest Medicines Shareholders Adopt 2025 Audited Financial Statements at AGM

Reuters
·
Jun 26

Movement Alert|Everest Medicines Falls 5.48% in Regular Trading, Nefecon Patent Settlement Sparks Continued Concerns Over Weakened Exclusivity Premium

Market Focus
·
Jun 26

Movement Alert|Everest Medicines Falls 5.15% in Regular Trading, Patent Settlement Allows First Generic of Core Drug Nefecon to Enter Market

Market Focus
·
Jun 25

Changan Huitong-backed Mico Pharma Jumps 103% in Hong Kong Debut After HKD 1.06 Billion IPO

Reuters
·
Jun 24

EVEREST MED Forges Commercial Partnership with Hainan Herui for Budesonide Enteric-Coated Capsules

Stock News
·
Jun 24

Everest Medicines Announces Mainland China Commercialization Deal with Hainan Herui for Budesonide Enteric Capsules

Bulletin Express
·
Jun 24

Everest Medicines - Enters Commercialization Collaboration With Hainan Herui Pharmaceutical for Budesonide Capsules

THOMSON REUTERS
·
Jun 24

Everest Medicines enters China commercialization collaboration with Hainan Herui for budesonide enteric capsules

Reuters
·
Jun 24

Everest Medicines' Substantial Shareholder Boosts Stake

MT Newswires Live
·
Jun 18

Hong Kong Market Announcement Highlights: Three IPOs Launch Including Optical Module Supplier, Lenovo Plans $2 Billion Convertible Bond Issue

Stock News
·
Jun 18

Major Shareholder Increases Stake in Everest Med

Stock News
·
Jun 18

Everest Medicines: CBC Group Adds 712,000 Shares for HK$19.20 Million, Lifting Accumulated Insider Buying to HK$172.50 Million

Bulletin Express
·
Jun 18

Everest Medicines - Cbc Group Purchases 712,000 Everest Medicines Shares for HK$19.2 Mln From 16 to 17 June

THOMSON REUTERS
·
Jun 18

Everest Medicines says CBC Group buys 712,000 shares for HK$19.2 million

Reuters
·
Jun 18

Everest Medicines shareholders approve share purchase agreement at EGM, 76.14% in favor

Reuters
·
Jun 17

Everest MED Shares Surge in Morning Trading Following Acquisition of Multi-Country Rights for Inhibitor DMX-200

Stock News
·
Jun 17

EVEREST MED Secures Exclusive Asian Rights to Promising FSGS Treatment Candidate DMX-200

Stock News
·
Jun 16

BUZZ-Australia's Dimerix soars on commercialisation deal with Everest Medicines

Reuters
·
Jun 16

Dimerix Ltd - Dimerix Licenses Dmx200 to Everest for China and Asia Region

THOMSON REUTERS
·
Jun 16